FDA Drug Application (020749) for LAMISIL by GLAXOSMITHKLINE CONS

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Application Number020749
Product Number001
FormSOLUTION;TOPICAL
Dosage1%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMISIL
Active IngredientTERBINAFINE HYDROCHLORIDE



Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.